IP and Antitrust Toolkit: Licensing Restraints, Pools, and Enforcement Conduct

By Casey Scott McKay · 2025-10-30

Intellectual property confers a right to exclude and antitrust law constrains how that right is used, and the boundary between them sits in a narrower and more specific place than practitioners on either side usually assume. This toolkit collects the doctrine, the drafting, and the compliance work in one place. It covers patent misuse after Princo, tying after Illinois Tool Works removed the presumption of market power, post-expiration royalty structuring under Kimble, and the narrow duty to deal after Trinko. It works pool governance and the essentiality review that distinguishes a product from a cartel, the ancillary restraints that carry the most exposure with the least attention, and the two routes that convert patent conduct into affirmative liability. It closes with a compliance programme, an investigation response, and a reading path.

IP and Technology > General IP | Toolkit | Published 30 October 2025 - Updated 30 December 2025 | Casey Scott McKay - marksy.us

Summary. Intellectual property confers a right to exclude and antitrust law constrains how that right is used, and the boundary between them sits in a narrower and more specific place than practitioners on either side usually assume. This toolkit collects the doctrine, the drafting, and the compliance work in one place. It covers patent misuse after Princo, tying after Illinois Tool Works removed the presumption of market power, post-expiration royalty structuring under Kimble, and the narrow duty to deal after Trinko. It works pool governance and the essentiality review that distinguishes a product from a cartel, the ancillary restraints that carry the most exposure with the least attention, and the two routes that convert patent conduct into affirmative liability. It closes with a compliance programme, an investigation response, and a reading path.

Keywords: IP antitrust toolkit · patent misuse · Princo narrowing · tying and market power · Illinois Tool Works · post-expiration royalties · Brulotte and Kimble · refusals to license · Trinko duty to deal · patent pools · essentiality review · grantbacks · non-challenge clauses · no-poach exposure · HSR reportability of licences · standards disclosure · Walker Process fraud · sham litigation · rule of reason record · compliance term schedule

Start Here

A licensing manager sends a draft to counsel with one question: is this term a problem?

The draft contains a field restriction, a running royalty, a grantback, a covenant not to challenge validity, and — three pages in, inherited from a template written for a different transaction — a mutual agreement not to solicit each other's employees.

Four of those terms are unremarkable. One of them is the most serious exposure in the document, carries criminal risk, and has received no thought at all.

That distribution is the ordinary condition of this practice. Most licensing terms are lawful and would remain lawful under any plausible enforcement policy. A small number require structuring. A smaller number should not be used. The skill is in sorting quickly, structuring competently, and escalating the genuine problems rather than treating everything as one.

The organising question is simple to state and does most of the work: what does the intellectual property actually confer, and does the restraint stay inside it?

A patent confers a right to exclude others from the claimed invention. It confers nothing else. Antitrust law does not object to the exclusion — that is the point of the system. It objects when the right is used as leverage to obtain something the patent never granted: control over unpatented goods, over markets the patent does not reach, or over periods after it has expired.

Inside that edge, exclusion is lawful. Outside it, the intellectual property supplies no defence and the conduct is analysed on ordinary principles, with the horizontal cases carrying the serious exposure.

This toolkit answers four questions.

What is the boundary? Misuse, tying, post-expiration royalties, and refusals to deal — the four doctrines that define where the grant ends.
How is a defensible arrangement drafted? Scope restraints, packages, grantbacks, non-challenge terms, and the hiring clause nobody reads.
What governance do pools and standards require? Independent essentiality review, complements not substitutes, and disclosure discipline.
What converts conduct into liability? Fraudulent procurement, sham litigation, and the enforcement records that defeat both.

A note on how to use it. The one-hour version — classify the relationship, ask whether the restraint stays inside the right, check market power, escalate competitor agreements — resolves the overwhelming majority of questions correctly. Reserve the deep analysis for the genuine problems. That is what makes a competition programme workable rather than obstructive, and an obstructive programme is one that gets bypassed.

The Four Boundary Doctrines

Patent misuse. An equitable defence rendering a patent unenforceable until the misuse is purged. It produces no damages and it is not a claim.

Morton Salt v. G.S. Suppiger is the foundation — a patentee conditioning a licence on the purchase of unpatented salt tablets could not enforce while the practice continued. Motion Picture Patents v. Universal Film supplies the underlying principle: the grant is limited to the claimed invention.

35 U.S.C. § 271 at subsection (d) removed the two most commonly asserted grounds. Refusal to license is expressly not misuse. Tying is misuse only with market power.

Princo v. International Trade Commission, en banc, narrowed the doctrine to conduct impermissibly broadening the physical or temporal scope of the grant with anticompetitive effect. Conduct that is merely anticompetitive without leveraging the grant is an antitrust question, not misuse.

The practical consequence. Do not plead misuse as a substitute for an antitrust counterclaim. A misplaced misuse defence costs credibility and invites an early adverse ruling.

Tying. Illinois Tool Works v. Independent Ink abolished the presumption that a patent confers market power. A plaintiff must prove market power in the tying product like any other plaintiff, and most patents confer none.

The elements that remain: two separate products, conditioning, market power, and a not-insubstantial amount of commerce. 15 U.S.C. § 1 and 15 U.S.C. § 14 supply the claims.

Eastman Kodak v. Image Technical Services permits aftermarket power notwithstanding primary market competition, subject to information and switching cost conditions.

Post-expiration royalties. Brulotte v. Thys prohibits a royalty for post-expiration use of an expired patent, and Kimble v. Marvel Entertainment reaffirmed it on stare decisis grounds while setting out the permitted structures expressly.

Refusals to license. Verizon Communications v. Trinko holds there is no general antitrust duty to deal. Aspen Skiing v. Aspen Highlands Skiing is the narrow exception — terminating a profitable existing course of dealing. In re Independent Service Organizations holds a patentee's unilateral refusal generally immune, while Image Technical Services v. Eastman Kodak treats a pretextual intellectual property justification as rebuttable. Federal Trade Commission v. Qualcomm reinforces the narrow reading.

The doctrine is worked at length in Where Intellectual Property Stops and Antitrust Starts.

Drafting the Restraints

Classify first. Vertical or horizontal, because it determines the standard. Vertical restraints go to the rule of reason and almost always survive; horizontal restraints on price, output, allocation, or hiring are per se unlawful regardless of the intellectual property.

Scope restraints — routine. Field of use, territory, quantity, customer class in a vertical licence. Continental T.V. v. GTE Sylvania supplies the framework.

Packages. Offer individual licences as a genuine alternative, priced so the choice is real. Permit removal of patents the licensee does not practise, with a stated adjustment. Record the efficiency rationale with figures. Keep evidence that some licensees have taken partial licences.

Post-expiration structuring. Deferred payment for pre-expiration use recited as a financing schedule; run-off to the last-expiring family member; hybrid allocation with a stepped-down know-how rate; foreign counterpart run-off; or a lump sum in instalments. Where a hybrid is used, the know-how must be real, separately identified, and genuinely delivered.

Grantbacks. Non-exclusive, limited to improvements to the licensed technology, limited to the licence's field, with consideration stated. Broad exclusive grantbacks transfer the improvement's value and attract scrutiny.

Non-challenge clauses. Replace a prospective prohibition with a termination right plus fee-shifting on unsuccessful challenges plus continued royalties during the challenge. It achieves most of the commercial purpose and is far more defensible.

Resale pricing. Leegin Creative Leather Products v. PSKS subjects minimum resale price agreements to the rule of reason federally, while several states apply a per se rule — a trap for national programmes.

The hiring clause. An agreement between competitors not to hire each other's employees is labour market allocation, per se unlawful, and prosecuted criminally. A narrow non-solicitation ancillary to a legitimate collaboration — restricted to project personnel, for the project's duration plus a short tail, limited to solicitation rather than hiring — is defensible. An open-ended mutual ban is not.

Draft it so ancillarity is apparent on the face of the document: same scope, same duration, same personnel as the collaboration.

The operational detail is in Structuring IP Arrangements That Survive Antitrust Review.

Market Power, Honestly

Why it comes before everything else. Market power is an element of most claims that reach licensing conduct, and its absence resolves the analysis. Illinois Tool Works v. Independent Ink removed the presumption that a patent supplies it.

The relevant market. Products reasonably interchangeable with the licensed product, in the geographic area where buyers can practically turn.

The error that recurs. Defining the market as the patented technology. If the patent covers one of four ways to achieve a result, the market includes all four and the share is a quarter rather than everything. A narrow definition prepared internally becomes the adversary's exhibit.

Indicators of power. High share sustained over time, entry barriers, the ability to raise price without losing volume, and the absence of viable substitutes.

Indicators against. Customers switching, competitors entering, prices constrained by alternatives, and design-arounds appearing in the field.

Where the evidence lives. Sales data, win-loss records, competitive analyses prepared by the business, pricing decisions, and customer feedback — which are the same documents an adversary will read.

Two-sided platforms. Ohio v. American Express requires a two-sided transaction platform to be analysed as one market accounting for both sides, which materially changes share calculations where intellectual property sits on a platform.

Aftermarkets. Eastman Kodak v. Image Technical Services permits aftermarket power notwithstanding primary-market competition, subject to conditions about information availability and switching costs — relevant to parts, consumables, and service.

The output. A short written assessment, prepared under privilege at counsel's direction, stating the market definition, the share estimate, and the basis. Update it when share moves materially.

Do not maintain a parallel unprivileged version. Business staff producing their own market analyses that contradict the privileged one is how a defensible position becomes a discovery problem.

Pools

What they do. Aggregate patents from multiple owners into a single licence at a published rate, with revenue shared. They reduce transaction costs, eliminate stacking within the membership, and resolve blocking positions.

Why they are generally procompetitive. Broadcast Music v. Columbia Broadcasting System is the analogue: a blanket licence combining thousands of works was not per se unlawful price fixing, because the product it created could not exist without the aggregation.

The governance conditions.

Independent essentiality review, engaged by the pool rather than by contributors, with a written procedure and published criteria.
Complements, not substitutes. Pooling patents all necessary to practise a technology creates a product; pooling patents that compete eliminates competition between them.
Non-exclusive contribution, so contributors may license bilaterally.
Open licensing to any implementer on published terms.
Published, non-discriminatory rates.
Information barriers, because contributors are frequently competitors.
Narrow grantbacks limited to essential patents.
Governance vested in an administrator with defined authority, not a contributors' rate-setting committee.
Periodic re-review, because patents expire and claims are amended.

Why the reviewer's independence is the critical condition. It is what distinguishes aggregating necessary rights from aggregating competing ones, and it is the first question an agency asks. A review conducted by the contributors is not a check.

Joining as a contributor — diligence. Compare the portfolio against the admission criteria and against the average contribution, since per-patent revenue sharing subsidises weaker portfolios. Read the grantback. Confirm the bilateral licensing right survives in writing. Understand withdrawal terms and whether granted licences survive. Understand how essentiality disputes are resolved and who pays.

Joining as a licensee — diligence. Confirm what the licence actually clears and identify essential patents outside it. Confirm rates and non-discrimination. Assess whether taking the licence affects the ability to challenge individual patents. Confirm coverage of affiliates, suppliers, and customers.

The residual risk. A pool licence is partial clearance, not an opinion.

Standards

The context. Standard-setting organisations bring competitors together to agree on technology, which is on its face a horizontal arrangement and which is generally procompetitive because interoperability creates value no participant could create alone.

Allied Tube & Conduit v. Indian Head removes immunity where the process is captured — a party packing a vote to exclude a competing technology has restrained trade rather than petitioned government.

American Society of Mechanical Engineers v. Hydrolevel imposes liability on the organisation for its agents' anticompetitive use of the apparatus, which is why organisations maintain strict procedural rules.

Disclosure obligations. Most policies require disclosure of patents believed essential to a proposed standard. Deliberate concealment followed by post-adoption assertion has been treated as an unfair method of competition under 15 U.S.C. § 45.

Practical protocol. Register participants. Read the policy literally, since obligations vary — some require a search, some only what the individual knows, some bind affiliates. Search and document where required. Disclose promptly, before adoption. Confirm whether declarations bind successors, which they generally do. Brief participants on prohibited discussion topics. Retain attendance records, disclosures, searches, and declarations.

On acquiring a portfolio, confirm what standards commitments transfer with it. A FRAND commitment runs with the patent, and an acquirer that assumed otherwise has overpaid.

The hold-up and hold-out debate. Enforcement policy has oscillated between treating implementers as vulnerable to hold-up and treating patentees as vulnerable to hold-out, and agency guidance has reversed more than once. Advise to the durable doctrine rather than the current guidance, and treat Federal Trade Commission v. Qualcomm as the leading modern authority on the duty-to-deal question in this setting.

Fraud and Sham Litigation

Two routes convert patent conduct into affirmative liability, and both are narrow.

Walker Process Equipment v. Food Machinery & Chemical. Enforcement of a patent obtained by knowing and wilful fraud on the Office can support a monopolisation claim under 15 U.S.C. § 2, stripping the immunity the patent would otherwise supply.

The elements are demanding. Fraud in procurement, proved by clear and convincing evidence. Enforcement of the patent so obtained. And the ordinary antitrust elements — relevant market, market power, and antitrust injury.

Higher than inequitable conduct, itself narrowed to but-for materiality and specific intent. A finding of inequitable conduct does not establish Walker Process fraud. The duty of candour sits at 37 C.F.R. § 1.56.

Eastern Railroad Presidents Conference v. Noerr Motor Freight immunises petitioning government, including litigating, however anticompetitive the intent.

Professional Real Estate Investors v. Columbia Pictures Industries sets the sham exception in two parts. The suit must be objectively baseless — no reasonable litigant could realistically expect success. Only then does the court reach subjective intent.

The objective prong is a real barrier. A suit surviving summary judgment is almost by definition not objectively baseless, and a plaintiff that wins cannot have brought a sham.

Both are defeated by the same discipline. A documented pre-filing analysis: claim charts per accused product, a validity assessment covering known art, standing and chain of title confirmed, any candour question assessed, and a written record kept under privilege.

Demand letters. Draft narrowly — patent, claims, accused product. Establish notice under 35 U.S.C. § 287. Avoid statements about outcomes. Note that a specific letter creates declaratory judgment exposure under MedImmune v. Genentech, which is a real trade-off between notice and forum.

State bad-faith assertion statutes regulate demand letters in most states, typically requiring identification of the patent, the claims, and the accused functionality, and empowering the attorney general. See state bad faith patent assertion statutes. Draft to the strictest applicable requirement as a matter of course, noting that federal law preempts state regulation absent objective bad faith.

Public statements. An assertion that a competitor infringes is commercial speech actionable under 15 U.S.C. § 1125 if objectively false.

Consistency. Apply the enforcement policy across similarly situated targets, because selective enforcement against a single competitor supports the inference that the purpose is competitive rather than protective.

Acquisitions and Reportability

The trap. Practitioners assume licences are never reportable. Exclusive licences transferring all commercially significant rights in a field are treated as asset acquisitions under 15 U.S.C. § 18a.

Screen at term sheet, on three questions. Is the grant exclusive, including as against the licensor? Does it transfer all commercially significant rights in a defined field, including the right to sue? Does the value exceed the threshold?

Structures that commonly trigger it. Exclusive licences of pharmaceutical compounds in a therapeutic field, exclusive platform licences, and sole-and-exclusive licences including enforcement rights.

Portfolio acquisitions. Assess whether the acquired patents read on the acquirer's competitors and whether the acquisition removes a competitive constraint under 15 U.S.C. § 18. In concentrated markets this is the substantive question, independent of reportability.

Transfers to assertion entities. Where a client transfers patents to an entity that will assert them against the client's competitors, document the business rationale contemporaneously. Privateering theories focus on transfers designed to raise rivals' costs while insulating the transferor from counterclaims.

Defensive aggregation among implementers is generally procompetitive and is itself a horizontal arrangement requiring governance — membership criteria, terms available to all members, and limits on information exchange.

Settlements between competitors. Federal Trade Commission v. Actavis subjects large and unexplained reverse payments to rule of reason scrutiny. Diagnostic questions: does value flow from patentee to alleged infringer, is any payment explained by documented avoided litigation costs, and is the entry date supported by a contemporaneous merits assessment? Non-cash consideration receives the same scrutiny and is harder to justify.

Copyright, Trademark, and Trade Secret

The doctrine above is patent-centric because that is where the cases are. The other regimes have their own boundary problems.

Copyright collective licensing. Broadcast Music v. Columbia Broadcasting System governs, and the performing rights organisations operate under long-standing consent decrees. A blanket licence combining rights that could not practicably be cleared individually is not price fixing; one used to prevent direct licensing is a different case.

Copyright misuse. Recognised in several circuits where the licence extends control beyond the copyright — conditioning a licence on an agreement not to develop competing products is the recurring example. The remedy is unenforceability during the misuse.

Interoperability. Refusing to license interface specifications, or asserting copyright in them to block compatible products, is where copyright and competition collide most directly. The fair use analysis in Google v. Oracle America does much of the work an antitrust claim would otherwise do.

Trademark. Rarely confers market power, because a mark identifies source rather than controlling technology. The issues arise in exclusive distribution enforced through trademark, refusals to supply distributors, resale restrictions overlapping with exhaustion, and franchise tying.

Franchise tying. Analysed under ordinary tying law, with the separate-products question turning on whether the supply is genuinely necessary to the format's quality. Quality control obligations under 15 U.S.C. § 1055 supply a justification but do not license unlimited sourcing restrictions. See When a Trademark License Becomes a Franchise.

Trade secrets and mobility. Non-competes and confidentiality obligations restrict labour mobility, and enforcement policy toward them has become substantially more aggressive. Overbroad restrictions are attacked both as unenforceable restraints and under competition law. See Where an Employee Can Go.

The Compliance Programme

Scope. Anyone who negotiates licences, participates in standards, or communicates with competitors.

The escalation rule, in one line. Any agreement with an actual or potential competitor goes to counsel before signature. No exceptions, because the exceptions are where the problems are.

The term schedule, published so ordinary deals move without counsel.

Routine — non-exclusive licences, field and territory restrictions in vertical deals, running royalties during the term, ordinary confidentiality.
Review required — exclusivity, packages and bundles, grantbacks, most-favoured-nation clauses, non-challenge provisions, post-expiration payment structures, any exclusive licence of a substantial asset.
Prohibited without specialist sign-off — any price, output, customer, or territory term affecting a competitor's product market; any hiring restraint with a competitor; any settlement involving payment from patentee to challenger.

Training. Short, concrete, repeated. Business staff do not need doctrine; they need to recognise the three or four situations that require a call.

Documentation standards. Teach people to state procompetitive purposes accurately in writing rather than to write nothing. Silence is not protective and reconstruction is worth little.

Standards protocol. Who attends, what is disclosed, what is not discussed, what is recorded.

Enforcement protocol. No assertion without a documented analysis, a template letter, and a single approver.

Privilege structure. Counsel directs the competition analysis, output is marked, and business staff do not maintain parallel unprivileged assessments. See What Your Adversary Gets to Read.

Audit. Sample executed agreements annually against the term schedule, because the gap between policy and practice is what an investigation finds.

Periodic review. Restraints lawful at five per cent share become questionable at forty. Reassess when share moves, when a competitor exits, or when a substantial portfolio is acquired.

Responding to an Investigation

The trigger. A civil investigative demand, a second request, a state inquiry, or a complaint naming the licensing programme.

Immediate steps. Issue a litigation hold covering licensing files, standards records, market assessments, pricing decisions, and competitor communications. Suspend routine destruction including on messaging platforms, which is where preservation failures occur. Identify custodians across licensing, business development, standards participation, and senior commercial management. Engage specialist counsel before responding to anything.

The document population is broader than expected: internal competitor analyses, board materials on market position, pricing models, and the correspondence in which the restraint was negotiated.

The market assessment. If prepared under privilege by counsel it is protected and valuable. If an unprivileged version exists, it is discoverable and will be quoted.

Witnesses. Prepare them on the procompetitive rationale for each restraint and on what they actually knew. A witness who cannot say why a term exists creates a record suggesting it has no legitimate purpose.

Parallel exposure. Investigations generate private treble damages litigation under 15 U.S.C. § 15 and follow-on class actions. Assume anything produced becomes available.

Insurance. Most policies exclude antitrust. Check the tower early rather than assuming coverage.

Remediation. Amending agreements during an investigation has evidentiary consequences and is a decision for specialist counsel, not a unilateral compliance response.

What This Costs

A restraint screen on an ordinary vertical licence takes an hour by someone who knows the sequence.

A market assessment takes two to five days the first time and half a day to refresh.

Pool contribution diligence takes a week, most of it reading the grantback and comparing the portfolio.

A standards protocol takes a day to write and a morning a year to maintain.

Reportability screening at term sheet takes an hour; discovering it at signing costs weeks and a filing fee.

A pre-filing analysis takes days per patent and is the cheapest insurance in the file.

Responding to a civil investigative demand costs more than the licensing programme earns in most years.

Private treble damages litigation costs more again, and is usually uninsured.

The asymmetry is the argument. A term producing marginal revenue and material exposure should be dropped, and that calculation is made too rarely. Reserve deep analysis for genuine problems, which is what keeps the programme workable.

Cadence

Per deal. Classification, restraint screen, and the rule of reason record where a review-required term is present.

Per quarter. Sample review of executed agreements against the term schedule.

Per year. Market assessment refresh; training; standards protocol review; audit; insurance check.

On event. Share movement, competitor exit, portfolio acquisition, pool invitation, a new enforcement programme, or receipt of any competition inquiry.

On template change. Re-screen the grantback, non-challenge, and hiring clauses specifically, because template drift is how old defects propagate silently.

Worked Scenarios

The consumables condition. A client sells patented equipment and wants to require customers to buy cartridges from it. Two products with separate demand, so the tie question is live. Market power in the equipment is the threshold — with three competing systems there is probably none, which resolves it. If power exists, the quality justification must be genuine: could an open specification achieve the same result? The structure that works is to sell cartridges competitively, publish a specification, and warrant only when specification-compliant supplies are used. That achieves the quality purpose without the condition.

The portfolio licence. A client with two hundred patents wants a single rate. Not a tie if individual licences are genuinely available. Publish per-patent and per-family rates alongside the portfolio rate, price the portfolio at a discount reflecting transaction cost savings, permit removal with a stated adjustment, and record that some licensees have taken partial licences.

The expiring flagship. The principal patent expires in three years and the licensee expects to sell for fifteen. Identify later-expiring family members and run to the last. Where none exist, price the pre-expiration use as total consideration payable over fifteen years, reciting that the schedule is financing. Where know-how transfers, allocate a stepped-down rate to it and make the transfer real.

The competitor cross-licence. Two firms in the same market propose a cross-licence with each taking a field. Horizontal, and reciprocal field restrictions mapping onto product markets are market allocation. Grant broadly across the technologies each needs, drop the reciprocal field limits, recite the freedom-to-operate purpose, and include no term touching price, output, customers, or hiring. Escalate before signature without exception.

The pool invitation. A client is asked to contribute twelve patents. How are they assessed against the criteria, who conducts essentiality review and who pays them, what is the per-patent share against the average, what does the grantback capture, does bilateral licensing survive, and what happens on withdrawal? Common outcome: contribute a subset, negotiate the grantback narrower, and confirm the bilateral right in writing.

The assertion programme. A client wants to assert against a competitor's customers. Lawful, and it produces the strongest bad-faith records. Requirements before proceeding: claim charts per accused product, a validity assessment covering known art, standing confirmed, letters drafted to the strictest state requirement, a single approver, and consistency across similarly situated recipients.

Questions Clients Ask

"Does our patent give us market power?" Almost certainly not. Illinois Tool Works v. Independent Ink removed the presumption and most patents have substitutes.

"Can we just refuse to license our competitor?" Yes. 35 U.S.C. § 271 excludes refusal from misuse and Verizon Communications v. Trinko rejects a general duty to deal. The exposure arises only if you are terminating an existing profitable relationship on a pretextual basis.

"Our royalty runs for twenty years — is that a problem?" Only if it runs on post-expiration use of an expired patent. Kimble v. Marvel Entertainment sets out the structures that achieve the same economics lawfully.

"Can we stop the licensee challenging our patent?" Not by prohibition. A termination right plus fee-shifting achieves most of the purpose and survives.

"Is a cross-licence with a competitor safe?" It depends entirely on whether the field grants map onto product markets. Escalate it.

"Do we have to report a licence?" Possibly. An exclusive licence transferring all commercially significant rights in a field is treated as an asset acquisition. Screen at term sheet.

"They're suing us — is that an antitrust violation?" Almost never. Professional Real Estate Investors v. Columbia Pictures requires objective baselessness first, and a suit surviving summary judgment is not objectively baseless.

"The agency guidance says…" Enforcement policy in this area has reversed direction repeatedly. Advise to the cases.

A Closing Note

The boundary is narrower than the folklore suggests, and it sits at the edge of what the intellectual property actually confers.

Inside that edge, exclusion is the point of the system, and the restraints implementing it are lawful and generally procompetitive. Outside it, the intellectual property supplies no defence.

Most licensing programmes need less caution than they exercise. A handful of terms in each need far more — and they are almost always the ones inherited from a template: the grantback, the non-challenge covenant, and the mutual non-solicitation clause that carries criminal exposure and receives the least attention in the document.

Classify the relationship, assess power honestly, structure the few terms that carry real constraints, and route every competitor agreement through counsel. That programme survives review, and it does so without obstructing the business it exists to protect.

Cross-Border Notes

European divergence. Competition law reaches licensing through a block exemption whose hardcore restriction list differs from US doctrine in ways that matter operationally. Exclusivity between competitors, non-challenge clauses, and certain output and price terms are treated more strictly, and the safe harbour depends on combined market shares.

The practical consequence. A licence operating in both systems is either drafted to the stricter rule throughout or drafted territorially with a schedule of variations. Assuming the US analysis travels is a recurring and expensive error, and it usually surfaces during a European transaction review years after signature.

Compulsory licensing. US law provides no general compulsory licence for patents, which distinguishes it from many systems. The narrow exceptions — government use under 28 U.S.C. § 1498, march-in rights under 35 U.S.C. § 203, and remedies in specific consent decrees — are the whole of it, and march-in has never been exercised.

Remedies as competition policy. Since eBay v. MercExchange, injunctive relief requires the traditional four-factor showing, and a patentee that does not practise the invention rarely obtains one. That single change has done more to limit hold-up in licensing negotiations than any competition doctrine, and it is worth stating to a client who believes an antitrust theory is the only answer to an aggressive assertion.

Foreign proceedings. Where a client operates internationally, a competition complaint in one system frequently follows an unsuccessful negotiation in another, and the documents produced in one proceeding travel. Advise on the international picture rather than jurisdiction by jurisdiction.

Working With Other Advisers

Specialist competition counsel for competitor agreements, pool formation, reportability, and any inquiry. Brief them with the classification and the market assessment rather than the whole file.

Prosecution counsel where a candour question exists, because prosecution conduct becomes a fraud element and prosecution counsel becomes a witness.

Economists engaged early where share is genuinely contested, and engaged under privilege.

Foreign counsel where the arrangement operates in systems treating exclusivity, non-challenge, and post-expiration terms differently.

Business leadership briefed on the escalation rule and why it exists, because a rule the commercial team resents is a rule that gets bypassed.

A Suggested Reading Path

For the doctrine:

For the standards dimension:

For the assertion and enforcement dimension:

For the aftermarket dimension:

Primary Authorities

| Authority | Proposition | |---|---| | 15 U.S.C. § 1 | Restraints of trade | | 15 U.S.C. § 2 | Monopolisation | | 15 U.S.C. § 14 | Tying; exclusive dealing | | 15 U.S.C. § 15 | Treble damages | | 15 U.S.C. § 18 | Acquisitions | | 15 U.S.C. § 18a | Premerger notification | | 15 U.S.C. § 45 | Unfair methods of competition | | 15 U.S.C. § 1125 | False statements in commerce | | 35 U.S.C. § 271 | Misuse limits at subsection (d) | | 35 U.S.C. § 287 | Marking and notice | | 37 C.F.R. § 1.56 | Duty of candour | | Morton Salt v. G.S. Suppiger | Misuse doctrine | | Motion Picture Patents v. Universal Film | Grant limited to the claimed invention | | Princo v. International Trade Commission | Misuse narrowed | | Illinois Tool Works v. Independent Ink | No presumed market power | | Eastman Kodak v. Image Technical Services | Aftermarket power | | Image Technical Services v. Eastman Kodak | Pretextual justification | | In re Independent Service Organizations | Refusal generally immune | | Brulotte v. Thys | Post-expiration royalties | | Kimble v. Marvel Entertainment | Permitted structures | | Verizon Communications v. Trinko | No general duty to deal | | Aspen Skiing v. Aspen Highlands Skiing | The narrow exception | | Federal Trade Commission v. Qualcomm | Licensing level | | Broadcast Music v. Columbia Broadcasting System | Blanket licences | | Continental T.V. v. GTE Sylvania | Vertical non-price restraints | | Leegin Creative Leather Products v. PSKS | Resale price maintenance | | National Collegiate Athletic Association v. Alston | Justifications must be proved | | Ohio v. American Express | Two-sided markets | | Walker Process Equipment v. Food Machinery | Fraudulent procurement | | Professional Real Estate Investors v. Columbia Pictures | Sham litigation | | Eastern Railroad Presidents Conference v. Noerr Motor Freight | Petitioning immunity | | Allied Tube & Conduit v. Indian Head | Standard-setting capture | | Federal Trade Commission v. Actavis | Reverse payments | | Antitrust guidelines for the licensing of intellectual property | Agency framework |

Forms and Templates

Competition work in a licensing practice produces two artefacts that decide outcomes, and both are documents rather than agreements. The first is the market assessment: a short memorandum prepared under privilege stating the relevant market, the share estimate, the substitutes, the entry conditions, and the basis for each. It is the single most useful document in a competition file, because market power is an element of most claims that reach licensing conduct and its absence resolves the analysis. The second is the rule of reason record: for each restraint requiring review, the anticompetitive effect a plaintiff would allege, the procompetitive justification with supporting evidence rather than assertion, and the less restrictive alternatives considered and rejected. National Collegiate Athletic Association v. Alston requires justifications to be proved, and contemporaneous business records are what prove them.

The License Agreement Template is the instrument the restraints sit in, and the terms requiring attention are the ones drafted from precedent: the grantback, the non-challenge provision, the royalty term relative to expiry, and any hiring restraint attached to a collaboration. The Portfolio Inventory Template adapts to the term schedule a compliance programme needs — one row per common licence term, classified routine, review-required, or prohibited without specialist sign-off, published so that ordinary deals move without counsel and unusual terms surface. The Assignment Agreement Template matters where an exclusive licence or portfolio transfer may be reportable under 15 U.S.C. § 18a, which practitioners assume is never the case and which is frequently wrong.

Related Toolkits and Checklists

The Standard Essential Patents and FRAND Toolkit covers the standards dimension in depth, including the declarations that run with a patent and the hold-up and hold-out debate that enforcement policy has oscillated across. The IP Antitrust Checklist runs the review in the order the questions arise, with gates before signature and before assertion. The Patent Assertion and Litigation Funding Toolkit covers the enforcement economics that sit behind Walker Process Equipment v. Food Machinery and sham litigation counterclaims. The Patent Licensing and Technology Transfer Toolkit covers the ordinary licensing framework these restraints modify. The Semiconductor and Hardware IP Toolkit covers an industry that runs on cross-licences, pools, and standards commitments, and where nearly every restraint in this toolkit appears in ordinary practice. And the IP Audit and Portfolio Governance Toolkit covers the register work that makes reportability screening and encumbrance review possible at all.